Applied Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
01 Giugno 2021 - 1:00PM
Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage
biopharmaceutical company developing a pipeline of novel drug
candidates against validated molecular targets in indications of
high unmet medical need, announced today that it will present
at the Goldman Sachs 42nd Annual Global Healthcare Conference on
Tuesday, June 8, 2021 at 1:20 p.m. ET.
Webcast information for this event will be
accessible on the Events page under the Investor Relations section
of the Applied Therapeutics website at www.appliedtherapeutics.com.
A replay will also be available following the webcast.
About Applied Therapeutics
Applied Therapeutics is a clinical-stage
biopharmaceutical company developing a pipeline of novel drug
candidates against validated molecular targets in indications of
high unmet medical need. The Company’s lead drug candidate, AT-007,
is a novel central nervous system penetrant aldose reductase
inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric
metabolic disease. The Company initiated a pivotal Phase 1/2
clinical trial in June 2019, read out positive top-line biomarker
data in adult Galactosemia patients in January 2020 and announced
full data from the trial in April 2020. A pediatric Galactosemia
study commenced in June 2020. The Company is also developing
AT-001, a novel potent ARI that is being developed for the
treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of
the heart. The Company initiated a Phase 3 registrational study in
DbCM in September 2019. The preclinical pipeline also includes
AT-003, an ARI designed to cross through the back of the eye when
dosed orally, for the treatment of diabetic retinopathy, as well as
novel dual PI3k inhibitors in preclinical development for orphan
oncology indications.
Contacts
Investors:Maghan Meyers or Brendan Burns(212)
600-1902 orappliedtherapeutics@argotpartners.com
Media:media@appliedtherapeutics.com
Grafico Azioni Applied Therapeutics (NASDAQ:APLT)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni Applied Therapeutics (NASDAQ:APLT)
Storico
Da Lug 2023 a Lug 2024